Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade F 68.0 3.14% 2.07
ABBV closed up 3.14 percent on Wednesday, June 26, 2019, on 5.52 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ABBV trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Fell Below 20 DMA Bearish 3.14%
MACD Bearish Signal Line Cross Bearish 3.14%
New 52 Week Closing Low Bearish 3.14%
Expansion Breakdown Bearish Swing Setup 3.14%

Older signals for ABBV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Chemistry Chemical Compounds Organic Compounds Pharmaceutical Products Autoimmune Diseases Prostate Cancer Chloroarenes Cardiology Cholesterol Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Lipoproteins Secondary Hyperparathyroidism Celiac Disease Exocrine Pancreatic Insufficiency Hypothyroidism Research Based Biopharmaceutical Testosterone Replacement Therapy
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 100.23
52 Week Low 65.06
Average Volume 7,625,201
200-Day Moving Average 83.731
50-Day Moving Average 78.0582
20-Day Moving Average 76.6835
10-Day Moving Average 76.165
Average True Range 2.4047
ADX 26.59
+DI 9.0421
-DI 49.6609
Chandelier Exit (Long, 3 ATRs ) 72.88589999999999
Chandelier Exit (Short, 3 ATRs ) 72.2741
Upper Bollinger Band 83.409
Lower Bollinger Band 69.958
Percent B (%b) -0.15
BandWidth 17.540931
MACD Line -1.6511
MACD Signal Line -0.6414
MACD Histogram -1.0097
Fundamentals Value
Market Cap 108.4 Billion
Num Shares 1.59 Billion
EPS 4.07
Price-to-Earnings (P/E) Ratio 16.71
Price-to-Sales 5.35
Price-to-Book 23.76
PEG Ratio 1.00
Dividend 2.56
Dividend Yield 3.76%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 70.42
Resistance 3 (R3) 70.28 69.35 70.01
Resistance 2 (R2) 69.35 68.73 69.41 69.88
Resistance 1 (R1) 68.67 68.35 69.01 68.81 69.74
Pivot Point 67.74 67.74 67.91 67.80 67.74
Support 1 (S1) 67.06 67.12 67.40 67.20 66.26
Support 2 (S2) 66.13 66.74 66.19 66.12
Support 3 (S3) 65.45 66.13 65.99
Support 4 (S4) 65.59